Clinical research in Rheumatology

Researchers

  • Cesar Diaz Return

    Clinical research in Rheumatology

  • Dacia Cerdá Gabaroi

    Clinical research in Rheumatology

    Phd
  • Daniel Roig Vilaseca

    Clinical research in Rheumatology

    Phd
  • Delia Reina Sanz

    Clinical research in Rheumatology

  • Marina Gonzalez

    Clinical research in Rheumatology

  • Montserrat Girabent Farrés

    Clinical research in Rheumatology

  • Park Hye Sang

    Clinical research in Rheumatology

  • Paula Estrada

    Clinical research in Rheumatology

  • Ramón Figuls

    Clinical research in Rheumatology

  • Sergio Heredia

    Clinical research in Rheumatology

  • Silvia Garcia Diaz

    Clinical research in Rheumatology

  • Vanessa Andrea Navarro Angeles

    Clinical research in Rheumatology

Contact the group

Form

Projects

    • Year 2014
    • Sant Joan Despí Moisès Broggi Hospital

    ASCORE study on long-term experience with abatacept sc in routine medical practice,

    • DISTRICT ATTORNEY:

      Bristol- Myres Squibb Research and Development

    • TYPE E:

      EPA

    • Year 2014
    • Sant Joan Despí Moisès Broggi Hospital

    Phase IV trial to evaluate the effect of residual inflammation assessed by means of imaging studies, drug concentrations and patient characteristics, in the result of the gradual reduction of the dose of adalimumab in patients with rheumatoid arthritis in clinical remission (PREDICTRA Study)

    • DISTRICT ATTORNEY:

      AbbVie Deutschland GmbH & Co. KG (AbbVie)

    • TYPE E:

      RD2004

    • Year 2014
    • Sant Joan Despí Moisès Broggi Hospital

    Pharmacokinetic/pharmacodynamic study of anti-TNF drugs (Etanercept, Adalimumab and Infliximab) in patients with rheumatoid arthritis,

    • DISTRICT ATTORNEY:

      Bellvitge University Hospital - Pharmacy Service

    • TYPE E:

      EPA

    • Year 2014
    • Sant Joan Despí Moisès Broggi Hospital

    Randomized clinical trial on the prevention of radiological progression with zoledronic acid in patients with early rheumatoid arthritis and low disease activity,

    • DISTRICT ATTORNEY:

      Dr. Carmen Gómez (University Hospital of Bellvitge)

    • TYPE E:

      RD2004

  • Clinical research in Rheumatology

    Researcher
    • Year 2013
    • Sant Joan Despí Moisès Broggi Hospital

    Factors predictive of immunological and ultrasound response in patients with active Rheumatoid Arthritis and candidates for biological therapy,

    • DISTRICT ATTORNEY:

      Hospital Sant Pau Research Foundation in collaboration with the Catalan Society of Rheumatology

    • TYPE E:

      PI

    • Year 2013
    • Sant Joan Despí Moisès Broggi Hospital

    Factors predictive of immunological and ultrasound response in patients with active Rheumatoid Arthritis and candidates for biological therapy,

    • DISTRICT ATTORNEY:

      Hospital Sant Pau Research Foundation in collaboration with the Catalan Society of Rheumatology

    • TYPE E:

      PINE TREE

  • Clinical research in Rheumatology

    Researcher
    • Year 2011
    • Sant Joan Despí Moisès Broggi Hospital

    Multi-country registry of clinical characteristics, including radiographic progression, and burden of disease over 5 years in real-life contexts in real-life setting) PROOF

    • DISTRICT ATTORNEY:

      AbbVie Farmacéutica SLU

    • TYPE E:

      EPA

    • Year 2011
    • Sant Joan Despí Moisès Broggi Hospital

    Multi-country registry of clinical characteristics, including radiographic progression, and burden of disease over 5 years in real-life contexts in real-life setting) PROOF

    • DISTRICT ATTORNEY:

      AbbVie Farmacéutica SLU

    • TYPE E:

      EPA

Lines of action

  • Rheumatoid arthritis and biological therapies
  • Osteoporosis and bone metabolism
  • Connectivopathies and autoimmune diseases
  • Periungual capillaroscopy
  • Joint ultrasound
  • Degenerative pathology of the musculoskeletal system
  • Spondyloarthropathies

Documents

Information of interest

Links